ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för dacarbazine. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

20 träffar

Bibliografisk träff 2018-01-05

Pharmacokinetics of dacarbazine (DTIC) in pregnancy.

Kantrowitz-Gordon I, Hays K, Kayode O, Kumar AR, Kaplan HG, Reid JM, Safgren SL, Ames MM, Easterling TR, Hebert MF.

Cancer Chemother Pharmacol · research-article; journal article; case reports; research support, n.i.h., extramural · DOI 10.1007/s00280-017-3511-6

Bibliografisk träff 2017-12-26

Toxicities, safeties and clinical response of dacarbazine-based chemotherapy on neuroendocrine tumors in Taiwan population.

Chiu HY, Lin LY, Chou WC, Fang WL, Shyr YM, Yeh YC, Mu-Hsin Chang P, Chen MH, Hung YP, Chao Y, Chien SH, Chen MH.

J Chin Med Assoc · journal article · DOI 10.1016/j.jcma.2017.08.020

Bibliografisk träff 2017-12-18

Effect of dacarbazine on CD44 in live melanoma cells as measured by atomic force microscopy-based nanoscopy.

Huang X, He J, Zhang HT, Sun K, Yang J, Wang H, Zhang H, Guo Z, Zha ZG, Zhou C.

Int J Nanomedicine · research-article; journal article · DOI 10.2147/ijn.s149107

Bibliografisk träff 2017-12-01

Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: a single institution phase II study.

Schinzari G, Rossi E, Cassano A, Dadduzio V, Quirino M, Pagliara M, Blasi MA, Barone C.

Melanoma Res · clinical trial, phase ii; journal article · DOI 10.1097/cmr.0000000000000401

Bibliografisk träff 2017-11-28

Dacarbazine nanoparticle topical delivery system for the treatment of melanoma.

Hafeez A, Kazmi I.

Sci Rep · research-article; journal article · DOI 10.1038/s41598-017-16878-1

Bibliografisk träff 2017-10-16

Combined pitavastatin and dacarbazine treatment activates apoptosis and autophagy resulting in synergistic cytotoxicity in melanoma cells.

Al-Qatati A, Aliwaini S.

Oncol Lett · research-article; journal article · DOI 10.3892/ol.2017.7189

Bibliografisk träff 2017-04-17

Efficacy of dacarbazine as a rescue agent for histiocytic sarcoma in dogs.

Kezer KA, Barber LG, Jennings SH.

Vet Comp Oncol · journal article · DOI 10.1111/vco.12314

Bibliografisk träff 2017-03-01

Dacarbazine inhibits proliferation of melanoma FEMX-1 cells by up-regulating expression of miRNA-200.

Chen YN.

Eur Rev Med Pharmacol Sci · journal article

Bibliografisk träff 2017-01-09

Sequential Combination Chemotherapy of Dacarbazine (DTIC) with Carboplatin and Paclitaxel for Patients with Metastatic Mucosal Melanoma of Nasal Cavity and Paranasal Sinuses.

Omata W, Tsutsumida A, Namikawa K, Takahashi A, Oashi K, Yamazaki N.

Clin Med Insights Case Rep · journal article; case reports; case-report · DOI 10.4137/ccrep.s39851

Bibliografisk träff 2017-01-01

Consideration of Preventing Local Venous Pain by Dacarbazine.

Ohtsubo T, Tsuji T, Umeyama T, Sudou M, Komesu K, Matsumoto M, Yoshida Y, Banno R, Tomogane K, Fujita A, Kohno T, Mikami T.

Yakugaku Zasshi · journal article · DOI 10.1248/yakushi.16-00222

Bibliografisk träff 2016-01-25

Dacarbazine.

Al-Badr AA, Alodhaib MM.

Profiles Drug Subst Excip Relat Methodol · review; journal article · DOI 10.1016/bs.podrm.2015.12.002

Bibliografisk träff 2013-02-01

Dacarbazine in melanoma: from a chemotherapeutic drug to an immunomodulating agent.

Ugurel S, Paschen A, Becker JC.

J Invest Dermatol · comment; journal article · DOI 10.1038/jid.2012.341

Bibliografisk träff 2012-09-20

Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma.

Engesæter B, Engebraaten O, Flørenes VA, Mælandsmo GM.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0045492

Bibliografisk träff 2011-06-09

Dacarbazine promotes stromal remodeling and lymphocyte infiltration in cutaneous melanoma lesions.

Nardin A, Wong WC, Tow C, Molina TJ, Tissier F, Audebourg A, Garcette M, Caignard A, Avril MF, Abastado JP, Prévost-Blondel A.

J Invest Dermatol · research support, non-u.s. gov't; journal article · DOI 10.1038/jid.2011.128

Bibliografisk träff 2011-06-01

Dacarbazine-based chemotherapy as first-line treatment in noncutaneous metastatic melanoma: multicenter, retrospective analysis in Asia.

Yi JH, Yi SY, Lee HR, Lee SI, Lim DH, Kim JH, Park KW, Lee J.

Melanoma Res · multicenter study; journal article · DOI 10.1097/cmr.0b013e3283457743

Bibliografisk träff 2010-01-16

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma.

Hersh EM, O'Day SJ, Powderly J, Khan KD, Pavlick AC, Cranmer LD, Samlowski WE, Nichol GM, Yellin MJ, Weber JS.

Invest New Drugs · clinical trial, phase ii; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1007/s10637-009-9376-8

Bibliografisk träff 2004-04-01

Killing and mutagenic actions of dacarbazine, a chemotherapeutic alkylating agent, on human and mouse cells: effects of Mgmt and Mlh1 mutations.

Sanada M, Takagi Y, Ito R, Sekiguchi M.

DNA Repair (Amst) · research support, non-u.s. gov't; journal article · DOI 10.1016/j.dnarep.2003.12.008

Bibliografisk träff 2002-08-01

Causative agent of vascular pain among photodegradation products of dacarbazine.

Asahi M, Matsushita R, Kawahara M, Ishida T, Emoto C, Suzuki N, Kataoka O, Mukai C, Hanaoka M, Ishizaki J, Yokogawa K, Miyamoto K.

J Pharm Pharmacol · journal article · DOI 10.1211/002235702320266280

Bibliografisk träff 2001-04-01

Validated high-performance liquid chromatographic assay for simultaneous determination of dacarbazine and the plasma metabolites 5-(3-hydroxymethyl-3-methyl-1-triazeno)imidazole-4-carboxamide and 5-(3-methyl-1-triazeno)imidazole-4-carboxamide.

Safgren SL, Reid JM, Rios R, Ames MM.

J Chromatogr B Biomed Sci Appl · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1016/s0378-4347(00)00586-7

Bibliografisk träff 2000-02-01

Toxicity, mutation frequency and mutation spectrum induced by dacarbazine in CHO cells expressing different levels of O(6)-methylguanine-DNA methyltransferase.

Psaroudi MC, Kyrtopoulos SA.

Mutat Res · research support, non-u.s. gov't; journal article · DOI 10.1016/s0027-5107(99)00220-1